MLchartDataset catalogue

HGS-ETR1

Term · Oncology and biomedicine · MLC-T-ONC-003872

A substance being studied in the treatment of some types of cancer. It binds to a protein called TRAIL R1 on the surface of some tumor cells. This may kill the tumor cells. HGS-ETR1 is a type of monoclonal antibody. Also called anti-TRAIL R1-mAb and mapatumumab.

Table 1. Record
IdentifierMLC-T-ONC-003872
FieldOncology and biomedicine
Expansionsanti-TRAIL R1-mAb; mapatumumab
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-003872",
  "term": "HGS-ETR1",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of some types of cancer. It binds to a protein called TRAIL R1 on the surface of some tumor cells. This may kill the tumor cells. HGS-ETR1 is a type of monoclonal antibody. Also called anti-TRAIL R1-mAb and mapatumumab.",
  "expansions": [
    "anti-TRAIL R1-mAb",
    "mapatumumab"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/hgs-etr1/"
}

Record 8,480 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.